Scienmag

MARCH 2, 2021

Process paves a road to safe, ethical, and fast drug manufacturing Credit: Rensselaer Polytechnic Institute TROY, N.Y. — Envisioning an animal-free drug supply, scientists have — for the first time — reprogrammed a common bacterium to make a designer polysaccharide molecule used in pharmaceuticals and nutraceuticals.

Bacteria 86

Bacteria Bacterium Drugs Scientist 86

Pharmaceutical Technology

OCTOBER 6, 2022

The company will create a comprehensive manufacturing process for NGoXIM to generate batches of the vaccine that are Good Manufacturing Practices-compliant. Therapyx will develop and manufacture the IL-12-containing microspheres in the vaccine called GneX12.

Vaccine 147

Vaccine Vaccination Development Bacterium 147

Pharmaceutical Technology

MAY 18, 2023

An investigational orally delivered biologic drug, LMN-201 is a cocktail of four therapeutic proteins that act synergistically to neutralise the C difficile bacterium and the toxin. It is compatible with standard-of-care antibiotics.

Bacterium 130

Bacterium Bacteria FDA Approval Trials 130

XTalks

APRIL 17, 2023

It was caused by contaminated ice cream products manufactured by Blue Bell Creameries, a popular ice cream company based in Texas. The outbreak was caused by the bacterium Listeria monocytogenes , which was found in several samples of Blue Bell ice cream products, as well as in the company’s manufacturing facilities.

Contamination 98

Contamination Bacterium Production Regulation 98

Roots Analysis

NOVEMBER 11, 2023

The Centers for Disease Control and Prevention (CDC) recently issued a formal health advisory in response to an unprecedented outbreak of carbapenem-resistant Pseudomonas aeruginosa (CRPA), a bacterium notorious for its resistance to specific antibiotics, thereby instigating severe infections in affected individuals.

Contamination 52

Contamination Bacterium Branding Bacteria 52

Pfizer

JANUARY 27, 2023

Trachoma is a neglected tropical disease (NTD) caused by the bacterium Chlamydia trachomatis. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. An estimated 1.9

Bacteria 75

Bacteria Medicine Containment Manufacturing 75

XTalks

AUGUST 2, 2023

Most of the company’s revenue comes from the manufacture and sale of biopharmaceutical products. every eight weeks for the 90 mg dose, according to the manufacturer. First FDA-approved in July 2017 for plaque psoriasis, the list price for a 30-day supply of Tremfya was stated to be $6,292, according to the manufacturer.

Sales 98

Sales Manufacturing FDA Approval Life Science 98